The move to the US has been good for a long term investor looking to average down. Shareprice down. AUD above parity. The rub of course is the share price needs to go up in the investor's lifetime and the AUD needs to go below parity for a happy ending.
The other rub is of course RP not flagging a near term raising at these depressed levels to fund one of our projects further.
For e.g. we'd need maybe $50 million to push Vapendavir through Ph III on our own. That's the reality RP faces as each month goes by without a deal happening in that program.
He's spent 5 months not saying a word, so he's made no effort to raise the share price to a level to accommodate a new raising and if the market reads the Vapendavir play like me, then a raising is a near certainty.
BTA Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held